Study investigating the prevalence of primary insomnia responsive to proton pump inhibitor treatment
Not Applicable
- Conditions
- primary insomnia
- Registration Number
- JPRN-UMIN000003626
- Lead Sponsor
- Department of Gastroenterology and Hepatology, Shimane University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
Usage of a sleeping medicine in 2 weeks. Cases treated as mental illness. Usage of PPI or H2RA in 2 weeks. With diseases that may influence sleep. Pregnant or lactating women. With allergy to omeprazole etc. Others which attending doctors decide not suitable.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Canges of QOLRAD-J, ESS, PSQI
- Secondary Outcome Measures
Name Time Method